Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation
Launched by KING CHULALONGKORN MEMORIAL HOSPITAL · Mar 1, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a medication called furosemide, which is commonly used after kidney transplants, can help predict how well a new kidney will function. The researchers want to see how much urine is produced after giving a specific dose of furosemide to patients who have received a kidney from a deceased donor. They believe that measuring this urine output can provide important information about the health of the transplanted kidney during recovery.
To be eligible for this trial, participants should be receiving a kidney transplant from a deceased donor at KCMH and must be willing to give their consent to join the study. However, individuals with a known allergy to furosemide, those who have complications from the surgery, or those who urgently need dialysis (a treatment for kidney failure) cannot participate. If you join the trial, you will receive furosemide, and the team will monitor how much urine your body produces afterward, helping researchers understand the kidney's performance in the days following the transplant.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Deceased donor kidney transplantation at KCMH
- • informed consent is accepted
- Exclusion Criteria:
- • Known allergy to furosemide
- • Surgical complication of allograft
- • Urgently needed for dialysis (refractory hypervolemia, uremic symptoms, and hyperkalemia)
About King Chulalongkorn Memorial Hospital
King Chulalongkorn Memorial Hospital, a leading medical institution in Thailand, is renowned for its commitment to advancing healthcare through innovative research and clinical trials. Affiliated with Chulalongkorn University, the hospital integrates cutting-edge medical practices with a robust academic framework, fostering an environment conducive to pioneering clinical studies. With a focus on improving patient outcomes and contributing to global medical knowledge, the hospital engages in a diverse range of clinical trials across various therapeutic areas, ensuring adherence to the highest ethical standards and regulatory guidelines. Through collaboration with healthcare professionals and researchers, King Chulalongkorn Memorial Hospital aims to enhance the quality of care while driving forward the frontiers of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangkok, , Thailand
Patients applied
Trial Officials
suwasin udomkarnjananun, M.D.
Principal Investigator
King Chulalongkorn Memorial Hospital and Chulalongkorn University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials